MYL6B, a myosin light chain, promotes MDM2-mediated p53 degradation and drives HCC developmentXingwang Xie, Hongsong Chen, Lai Wei et al.|Journal of Experimental & Clinical Cancer Research|2018Cited by 26
Reversing P-glycoprotein-mediated multidrug resistance in vitro by α-asarone and β-asarone, bioactive cis–trans isomers from Acorus tatarinowiiXue Meng, Xiaohui Zheng, Sha Liao et al.|Biotechnology Letters|2013Cited by 25
Oncolytic Adenovirus Armoring with <i>CXCL9</i> and <i>IL15</i> Shows Potent Antitumor Activity and Boosts CAR-T Therapy for Prostate CancerLin Fang, Gang Wang, Xueyan Wang et al.|Human Gene Therapy|2025Cited by 8
Oncolytic Adenovirus-Mediated Expression of CCL5 and IL12 Facilitates CA9-Targeting CAR-T Therapy Against Renal Cell CarcinomaLin Fang, Junnian Zheng, Weiping Tian et al.|SSRN Electronic Journal|2022Cited by 1